Suppr超能文献

4-氨基吡啶在重症肌无力中的作用。

Effects of 4-aminopyridine in myasthenia gravis.

作者信息

Lundh H, Nilsson O, Rosén I

出版信息

J Neurol Neurosurg Psychiatry. 1979 Feb;42(2):171-5. doi: 10.1136/jnnp.42.2.171.

Abstract

A new drug, 4-aminopyridine, was prepared for use in humans and tested by repeated injections in six patients with myasthenia gravis. The drug caused improvement of muscle strength and neuromuscular transmission as demonstrated by clinical observations and repetitive electrical nerve stimulation. The drug was effective in cases without any other treatment as well as in cases undergoing treatment with anticholinesterases. It is concluded that 4-aminopyridine may be of value as a supplementary drug in the treatment of myasthenia gravis.

摘要

一种名为4-氨基吡啶的新药被制备用于人体,并在6例重症肌无力患者身上进行了重复注射测试。临床观察和重复神经电刺激表明,该药物可改善肌肉力量和神经肌肉传递。该药物在未接受任何其他治疗的病例以及接受抗胆碱酯酶治疗的病例中均有效。得出结论,4-氨基吡啶作为重症肌无力治疗的辅助药物可能具有价值。

相似文献

1
Effects of 4-aminopyridine in myasthenia gravis.4-氨基吡啶在重症肌无力中的作用。
J Neurol Neurosurg Psychiatry. 1979 Feb;42(2):171-5. doi: 10.1136/jnnp.42.2.171.
3
4-aminopyridine-a review.4-氨基吡啶——综述
Anaesth Intensive Care. 1982 May;10(2):120-6. doi: 10.1177/0310057X8201000205.
6
Novel drug of choice in Eaton-Lambert syndrome.伊顿-兰伯特综合征的新型首选药物。
J Neurol Neurosurg Psychiatry. 1983 Jul;46(7):684-5. doi: 10.1136/jnnp.46.7.684.

引用本文的文献

本文引用的文献

5
Acetylcholine-induced channels and transmitter release at human endplates.
Nature. 1978 Jan 5;271(5640):74-5. doi: 10.1038/271074a0.
6
Effects of 4-aminopyridine on neuromuscular transmission.4-氨基吡啶对神经肌肉传递的影响。
Brain Res. 1978 Sep 22;153(2):307-18. doi: 10.1016/0006-8993(78)90409-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验